DCL-1 (CD302) is a novel C-type lectin receptor, discovered as a genetic fusion partner of DEC-205 (CD205), a C-type lectin that delivers antigen from the surface into DC antigen processing pathway (

J. Biol. Chem.
2003
.
278
:
34035
). We have now examined the molecular nature and expression of DCL-1. DCL-1 contains an external single C-type lectin-like domain followed by a transmembrane and cytoplasmic domain with putative signaling and endocytic motifs. The DCL-1 gene, consisting of 6 exons, was mapped to chromosome 2q24, approximately 5 kb downstream of the DEC-205 gene. Human DCL-1 has 76% protein identity to the mouse ortholog, suggesting its highly conserved function. Northern blot analysis showed that the 4.2 kb DCL-1 mRNA was present in myeloid cell lines, but not in T and B cell lines. Specialized phagocytic cells (i.e. monocytes, macrophages, granulocytes), monocyte-derived DC (MoDC) and blood DC (BDC) expressed DCL-1 mRNA, detected by RT-PCR. Immunoprecipitation/ Western blot (IP/WB) analysis using FLAG-tagged DCL-1 transfectants detected a broad band (modal size 35 kDa), which became a single 26 kDa band after N-glycosidase F digestion, indicating that DCL-1 is N-glycosylated. Flow cytometry studies with DCL-1 mAb (MMRI-20, developed in house) detected moderate levels of DCL-1 expression on granulocytes, monocytes, macrophages, MoDC and BDC, but not on lymphoid cells. Concomitant WB/IP analysis using the DCL-1 mAb detected 26 and 33 kDa doublets in monocytes, macrophages and MoDC. DCL-1 transfectants, macrophages, MoDC and BDC endocytosed cell surface DCL-1 after crosslinking with the DCL-1 mAb. DCL-1-Ig fusion protein bound to GlcNAc- and Man-conjugated beads, but not to GalNAc-, Fuc- and mannan-conjugated beads in a calcium-dependent manner. Thus, DCL-1 is expressed by phagocytes and DC, behaves as a C-type lectin, and is likely to be involved in endocytosis/phagocytosis of microbes. We are exploiting DCL-1 as a potential antigen-loading receptor for DC tumor immunotherapy.

Topics:
antigen-presenting cells, c-type lectins, tumor antigens, monoclonal antibodies, antigens, rna, messenger, calcium, flow cytometry, fusion proteins, glycoside hydrolases

This work is supported by National Health and Medical Research Council of Australia.

Author notes

Corresponding author

2005, The American Society of Hematology
2005
Sign in via your Institution